Skip to main content

Peer Review reports

From: Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells

Original Submission
19 Oct 2017 Submitted Original manuscript
27 Nov 2017 Reviewed Reviewer Report - Les Tolle
30 Nov 2017 Reviewed Reviewer Report - Claudia Staab-Weijnitz
22 Dec 2017 Author responded Author comments - Maria Molina Molina
Resubmission - Version 2
22 Dec 2017 Submitted Manuscript version 2
16 Jan 2018 Reviewed Reviewer Report - Claudia Staab-Weijnitz
25 Jan 2018 Reviewed Reviewer Report - Les Tolle
27 Feb 2018 Author responded Author comments - Maria Molina Molina
Resubmission - Version 3
27 Feb 2018 Submitted Manuscript version 3
7 Mar 2018 Reviewed Reviewer Report - Les Tolle
20 Mar 2018 Reviewed Reviewer Report - Claudia Staab-Weijnitz
11 Apr 2018 Author responded Author comments - Maria Molina Molina
Resubmission - Version 4
11 Apr 2018 Submitted Manuscript version 4
12 Apr 2018 Author responded Author comments - Maria Molina Molina
Resubmission - Version 5
12 Apr 2018 Submitted Manuscript version 5
Publishing
16 Apr 2018 Editorially accepted
27 Apr 2018 Article published 10.1186/s12890-018-0626-4

You can find further information about peer review here.

Back to article page